Amgen Falls After Revenue Growth Misses Estimates

Amgen Inc., the world’s largest biotechnology company, declined the most in four years after reporting sales growth that missed analysts’ estimates.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.